Array’s (NASDAQ:ARRY) Q3 2026 sales beat estimates but full-year sales guidance misses expectations significantly
Array’s (NASDAQ:ARRY) Q3 2026 sales beat estimates but full-year sales guidance misses expectations significantly StockStory
Covered in this story
Analyst targets on Array Technologies Inc
- Susquehanna: $3.43 → $4 by Oct 2027 · Neutral via Timothy Sykes
- Barclays: $3.43 → $4 by Oct 2027 · Equal Weight via Timothy Sykes
- UBS: $3.43 → $5 by Oct 2027 · Neutral via Timothy Sykes
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ARRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Array Technologies Inc →Summary aggregated from StockStory's public RSS feed. The full reporting belongs to StockStory — please read it on their site.